Ratan Capital Management LP Relay Therapeutics, Inc. Transaction History

Ratan Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$20.26 - $32.36 $1.01 Million - $1.62 Million	-50,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$26.0 - $37.03 $52,000 - $74,060	2,000 Added 4.17%	50,000 $1.54 Million
Q3 2021 Nov 15, 2021	SELL	$29.75 - $37.99 $952,000 - $1.22 Million	-32,000 Reduced 40.0%	48,000 $1.51 Million
Q2 2021 Aug 16, 2021	SELL	$27.5 - $38.19 $687,500 - $954,750	-25,000 Reduced 23.81%	80,000 $2.93 Million
Q1 2021 May 21, 2021	BUY	$32.52 - $61.53 $1.14 Million - $2.15 Million	35,000 Added 50.0%	105,000 $3.63 Million
Q3 2020 Nov 16, 2020	BUY	$32.81 - $45.1 $2.3 Million - $3.16 Million	70,000 New	70,000 $2.98 Million

203

156M

207K

40K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $614M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Ratan Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Ratan Capital Management LP with notifications on news.